Hypertension following sternotomy is common in patients undergoing cardiac surgery. The resulting increases in left ventricular work load and myocardial oxygen consumption are particularly undesirable in patients with coronary artery disease. The frequency of hypertension in patients undergoing coronary artery surgery, anaesthetized with fentanyl 60-75 ^g kg" 1 , has been reported as 40-60% (Sebel et al., 1982) , and although this can be decreased to 10-15 % by the administration of fentanyl in doses of up to 150-200 ng kg" 1 , unacceptable prolongation of postoperative respiratory depression may result (de Lange et al., 1982; Wynands et al., 1983) .
Nitroglycerine is used frequently to control intraoperative hypertension in this situation, primarily because it has a favourable effect on myocardial oxygen balance: its venodilating effect causes decreases in ventricular filling pressures and volume and, thereby, in wall tension (preload reduction). It may also improve the endocardial: epicardial blood flow ratio by dilating the coronary arteries and increasing collateral blood flow. In higher doses it causes arteriolar dilatation (afterload reduction). Unlike nitroprusside, it is non-toxic, does not produce an "intra-coronary steal" and there is less tendency for overshoot hypotension. Flaherty and colleagues (1982) reported that nitroglycerine may be a suitable alternative to nitroprusside for maintaining arterial pressure within acceptable limits.
The calcium-channel blockers, verapamil and nifedipine, are effective antianginal agents when administered by mouth (Braunwald, 1982) : both dilate peripheral and coronary arteries and this property suggests that they may be of value in the intraoperative management of patients with coronary artery disease. Verapamil has been used as a hypotensive agent during neuroleptanaesthesia (Zimpfer, Fitzal and Tonczar, 1981) and in the initial treatment of severe hypertensive crisis (Singh, Ellrodt and Peter, 1978) .
This study compared the efficacy and side-effects of nitroglycerine, verapamil and nifedipine when used to control arterial pressure during coronary artery surgery.
PATIENTS AND METHODS
Eighty patients scheduled for elective coronary artery surgery were studied. Informed consent was obtained at the preoperative visit. Patients with a left ventricular end-diastolic pressure (LVEDP) greater than 15 mm Hg, an ejection fraction less than 50%, A-V conduction disturbances or who had taken digoxin within the previous 14 days were excluded. Those undergoing additional surgery, such as valve replacement or aneurysmectomy were also excluded. Except for nitrates, all medication was discontinued the evening before surgery.
Patients were randomly allocated to one of four groups (20 patients per group). Group I received no vasodilator therapy before sternotomy and served as a control group; group II received an infusion of nitroglycerine at an initial rate of 0.7 ug kg" 1 min" 1 ; group III received an infusion of verapamil at an initial rate of 10 ug kg" 1 min" 1 (following a loading bolus of 70 ug kg" 1 ); group IV received an infusion of nifedipine at an initial rate of 0.7 ug kg" 1 min" 1 (following a loading bolus of 5 fig kg" 1 ). All infusions were given via a syringe pump using polypropylene syringes and infusion lines. Since nifedipine undergoes rapid decomposition in the presence of light, special black syringes and connecting tubing were used.
Lorazepam 4-5 mg was given by mouth 1.5 h before surgery. On arrival in the operating theatre, the ECG was connected, and two wide-bore peripheral cannulae and a radial artery cannula were inserted under local analgesia. After preoxygenation, pancuronium 2 mg was administered i.v., followed by fentanyl 75 ug kg" 1 over 2 min. When the patient became unresponsive to commands, a further 6 mg of pancuronium was given and ventilation assisted and then controlled manually. Three minutes later the trachea was intubated. Ventilation of the lungs was continued with air-oxygen (Fi^ = 0.5) and adjusted to maintain an end-tidal Pco, of 4-4.5%. A triplelumen flow-directed thennodilution catheter (Edwards Laboratories, Santa Ana, Cal.) was placed in the pulmonary artery. Between intubation and start of surgery an additional dose of fentanyl (25 ug kg" 1 ) was given. A series of control haemodynamic measurements was obtained, and vasodilator therapy started before the preparations for surgery. The rate of the appropriate infusion was adjusted to maintain a systolic arterial pressure less than 120% of pre-infusion (control) value and was continued, as required, until the start of cardiopulmonary bypass. Hypertension (denned as an increase in systolic arterial pressure > 20 % above preincision values) after sternotomy in group I patients was treated with an infusion of sodium nitroprusside. Further haemodynamic measurements were obtained at 5-min intervals until 10-15 min after sternotomy. Cardiac output was measured by the thennodilution technique using a bolus of 5 ml of saline at 0 °C. The average of at least three measurements was recorded.
Haemodynamic data were analysed using two-way analysis of variance. Where indicated, a modified r test was used to identify significant differences between and within groups, using critical values of P calculated according to the method of Bonferroni (Wallenstein, Zucker and Fleiss, 1980) . The chi-squared test was used to analyse non-parametric data. A value of P < 0.05 was considered significant. Results are reported as mean±SEM.
RESULTS
Relevant details of the patients are shown in table I. The groups were comparable with respect to age, weight, preoperative ejection fraction, LVEDP and preoperative drug therapy. The average infusion rates, and their durations of administration are shown in table II.
Measured and calculated haemodynamic variables before the start of vasodilator infusion, immediately pre-incision and at times of maximum change after skin incision and sternotomy are shown in table III. In group I (fentanyl only) all measurements were completed before starting sodium nitroprusside (if required). Control haemodynamic variables between the groups were not statistically different. The lower mean systolic arterial pressure (SAP) in group I was caused by the random inclusion of four patients with control 
Systemic arterial pressure
In group I (fentanyl only) systolic and mean arterial pressures increased significantly above control values following skin incision (P < 0.05) and sternotomy (P < 0.01). In the groups receiving nitroglycerine and verapamil, systolic and mean arterial pressures decreased significantly immediately before incision. In the nifedipine group no significant changes occurred at any time during this study.
Heart rate (HR) Significant (P < 0.05) increases in HR occurred in the verapamil and nifedipine groups following sternotomy. At this time, there were similar increases in HR in the fentanyl and nitroglycerine groups, but the differences from control values did not reach statistical significance.
Mean pulmonary artery pressure PKP increased significantly after sternotomy in the fentanyl (P < 0.05) and verapamil (P < 0.01) groups. PKP was significantly lower in the nitroglycerine group than in the other groups after incision (P < 0.05). Following sternotomy, it was lower in the nitroglycerine group than the fentanyl (P < 0.01) or nifedipine groups (P < 0.05). PAP in the nifedipine group was also significantly lower than in the verapamil group (P < 0.01).
Pulmonary capillary wedge pressure (PCWP)
After sternotomy there were significant increases in PCWP in the fentanyl (P < 0.05) and verapamil (P < 0.01) groups. The PCWP in the verapamil group was significantly higher (P < 0.01) than in the nitroglycerine and nifedipine groups following sternotomy. Nitroglycerine induced a non-significant decrease in PCWP compared with control values at all times up to cardiopulmonary bypass. PCWP was significantly lower in the nitroglycerine group than in the fentanyl group pre-incision (P < 0.05), post-incision (P < 0.05) and following sternotomy (P < 0.01).
Cardiac index
No statistical differences occurred within the groups. Cardiac index was significantly lower in the nitroglycerine group, compared with the nifedipine group following skin incision (P < 0.05) and sternotomy (P < 0.01). There was also a significant difference between the nitroglycerine and verapamil groups (P < 0.01) following sternotomy.
Rate-pressure product
Rate-pressure product decreased significantly (P < 0.05) following drug administration in the verapamil group, but not in the groups receiving nifedipine or nitroglycerine. In the fentanyl group there was a significant increase above the control value after sternotomy (P < 0.01).
Effect of preoperative oral medication
In all groups the responses were similar in patients taking preoperative oral nifedipine compared with those not taking oral nifedipine Electrocardiography Electrocardiographic data after sternotomy are shown in table IV. There was a significant prolongation of the P-Q interval in patients receiving verapamil. In six of these patients (30 %) the maximum P-Q interval was greater than 200 ms, which is, by definition, 1st degree heart block. No patients developed 2nd or 3rd degree heart block. QRS and Q-Tc intervals in this group were not significantly prolonged when compared with control values. There were no significant ECG changes in the other groups. There were no ST-segment changes in any group.
Fifty-seven per cent of the patients receiving verapamil required pacing after cardiopulmonary bypass. In the other groups the incidences were: fentanyl 0%, nitroglycerine 20% and nifedipine 16 %. In the verapamil group, 57 % of the patients required inotropic support with dopamine after bypass. The percentages in the other groups were: fentanyl 19 %, nitroglycerine 40 % and nifedipine 16 %. Whereas in the fentanyl, nitroglycerine and nifedipine groups dopamine was needed for only short (5-15 min) periods at the end of cardiopulmonary bypass, four patients who received verapamil required continuous inotropic support into the postoperative period. The frequency of pacing, and of the requirement for dopamine, was significantly greater (P < 0.01) in the verapamil group than in the other groups.
DISCUSSION
Hypertension following sternotomy is particularly prevalent in patients undergoing coronary artery surgery. If untreated it may expose the patient to the risk of peri-operative infarction because of the increases in myocardial work load and oxygen demand. The frequency of hypertension tends to be greater in patients anaesthetized with large doses of opioids, possibly because these drugs cause only minimal myocardial depression or peripheral vasodilatation. Although the addition of potent inhalation anaesthetics, such as halothane, can control such hypertension, high concentrations are often required. Hess and colleagues (1983) found that halothane concentrations of 1.0-1.5 % were required to control hypertension following sternotomy in patients anaesthetized with fentanyl. This was accompanied by an 18% decrease in cardiac index. The majority of patients undergoing coronary artery surgery have been taking betaadrenergic blocking drugs. Halothane depresses ventricular function (Maunuksala, 1977) , especially in the presence of beta-adrenergic blockade (Stephen, Dave and Scott, 1971 ). Therefore, we prefer to control hypertension with i.v. nitroglycerine which decreases arterial pressure by dilating both arteries and veins, vasodilatation in the latter usually being predominant (Gerson et al., 1982) . These decreases in left ventricular preand afterload are accompanied by coronary vasodilatation and decreases in myocardial oxygen consumption (Moffitt et al., 1983) , and in the endocardial: epicardial perfusion ratio in both ischaemic and non-ischaemic regions (Flaherty et al., 1976) . In contrast, nitroprusside can produce sub-endocardial ischaemia because of an intracoronary steal phenomenon (Chiariello et al., 1976; Capurro, Kent and Epstein, 1977; Mann et al., 1978) and, thus, its administration be detrimental. Calcium-channel blocking drugs, by inhibiting the transmembrane transport of calcium ions, produce dilatation of both peripheral and coronary arteries (Golenhofen and Hermstein, 1975; Fleckenstein, 1981) . They are used in the management of angina pectoris where their beneficial effect is probably caused by a reduction of myocardial oxygen demand following a decrease in left ventricular afterload, and an increase in myocardial oxygen supply from dilatation of the coronary vessels. Direct intracoronary administration of nifedipine results in an increase in coronary artery diameter in bothnormal and post-stenotic segments and a decrease in coronary arteriolar resistance (Simonson, 1978; Serruys et al., 1981) . During ischaemia, intracoronary administration of nifedipine results in a decrease in myocardial lactate production (Serruys et al., 1983) .
Verapamil produces more myocardial depression than nifedipine, although its negative inotropic action may be substantially minimized by a decrease in afterload so that cardiac output remains unchanged (Ferlinz, Easthope and Aranow, 1979) . Verapamil is also a more potent depressor of S-A and A-V nodal function than is nifedipine (Singh and Roche, 1977; Kawai, Konishi and Matsuyama, 1981) . Verapamil is widely used as an anti-arrhythmic drug, whereas nifedipine appears to be devoid of a direct anti-arrhythmic effect (Henry et al., 1979) . Bolus administration of verapamil 7.5 ug kg" 1 i.v. during morphine-diazepam-nitrous oxide anaesthesia produced hypotension without significant changes in heart rate or cardiac output (Kates and Kaplan, 1983) . The use of a single i.v. bolus of verapamil 70 ug kg~l to electively decrease systemic arterial pressure during neuroleptanaesthesia has been described (Zimpfer, Fitzal and Tonczar, 1981) .
In the present study, decreases of 20-30 % in arterial pressure occurred after the initial bolus of verapamil 70 ug kg" 1 . However, large doses of verapamil were required to maintain control of arterial pressure after sternotomy. Although cardiac output was well maintained, significant increases in PKP and PCWP occurred, with values greater than those in the control (fentanyl only) group. This can be explained by verapamil-induced myocardial depression. Patients with coronary artery disease often have a hyperactive haemodynamic system, and some degree of myocardial depression during periods of surgical stress may be beneficial on account of the associated decrease in oxygen consumption by the myocardium. Nonetheless, the 60 % increase in PKP observed in this study is unacceptable.
The prolongation of the P-Q interval in the verapamil group was not unexpected. Indeed, one might have anticipated even greater changes, since almost all patients were receiving beta-adrenergic blocking drugs until the evening before surgery. It is generally assumed that the combination of verapamil and beta-adrenergic blocking drugs may result in severe bradycardia. Bradycardia did not occur in any of our patients and there was even a significant increase in heart rate following sternotomy in the patients receiving verapamil.
The depressant effects of verapamil on A-V conduction and myocardial contractility were still present following cardiopulmonary bypass, with significantly more patients requiring pacing and inotropic support than in the other groups. These findings, together with the large increase in PKP and PCWP before bypass suggest, in our opinion, that verapamil is not a suitable drug for controlling arterial pressure in patients undergoing cardiac surgery.
The patients given nifedipine remained haemodynamically stable and the overall results were similar to those in the nitroglycerine group. However, nifedipine did not cause the decreases in PKP and PCWP seen with nitroglycerine.
The effects of nifedipine and verapamil on arterial pressure occur primarily via a reduction in arteriolar resistance. Although there were no statistically significant changes in systemic vascular resistance (SVR) in this study, SVR decreased in both the nifedipine and verapamil groups, but not in the nitroglycerine group. Nitroglycerine has a primary dilating effect on the venous system, causing a reduction in preload in low doses (1-2 |ig kg" 1 min" 1 ). Larger doses (up to 4 ug kg" 1 min" 1 ) are required to produce arterial hypotension and decreases in afterload.
In conclusion, we have demonstrated that both nitroglycerine and nifedipine are effective in the control of arterial pressure during coronary artery surgery. However, it must be emphasized that all the patients in this study had good left ventricular function and it is impossible to extrapolate our findings to other groups of patients. Verapamil, becauseofits depression of myocardial contractility and A-V conduction is unsuitable in this context. Nifedipine deserves further investigation as an anti-hypertensive agent for patients undergoing coronary surgery.
